December 2010. Volume 6. Number 4

The multiple faces of conflict of interest and its implications in clinical practice

 
 
 
 
 
 
 
 
 
 
Rating: 5 (1 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

ED | Editorial

Author: Fernández Oropesa C1.
1Servicio de Uso Racional del Medicamento. Subdirección de Farmacia y Prestaciones. Servicio Andaluz de Salud. Sevilla. España.
Correspondence: Carlos Fernández Oropesa. Email: carlosf.oropesa@elrincondesisifo.es
Publication date: 18/11/2010

How to cite this article

Fernández Oropesa C. Las múltiples caras del conflicto de intereses y sus implicaciones en la práctica clínica. Evid Pediatr. 2010;6:71.

ED | Editorial

Author: Fernández Oropesa C1.
1Servicio de Uso Racional del Medicamento. Subdirección de Farmacia y Prestaciones. Servicio Andaluz de Salud. Sevilla. España.
Correspondence: Carlos Fernández Oropesa. Email: carlosf.oropesa@elrincondesisifo.es
Publication date: 18/11/2010

How to cite this article

Fernández Oropesa C. Las múltiples caras del conflicto de intereses y sus implicaciones en la práctica clínica. Evid Pediatr. 2010;6:71.

References

  1. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors’ conclusions: epidemiological study of randomized clinical trials published in the BMJ. BMJ. 2002;325:249.
  2. Editorial. Sponsorship, Authorship, and Accountability. N Engl J Med. 2001;345:825-7.
  3. Editorial. Toward More Uniform Conflict Disclodures. The Updated ICMJE Conflict of Interest Reporting Form. N Eng J Med. 2010;363:188-9.
  4. Fugh-Berman AJ. The Haunting of Medical Journals: How Ghostwriting Sold “HRT”. PLoS Med. 2010;7:e1000335.
  5. Steinbrook R. Controlling Conflict of Interest. Proposals from the Institute of Medicine. N Eng J Med. 2009;360:2160-3.
  6. Smith R. Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies. PLoS Med. 2005;2:e138.
  7. Burgeois FT, Murthy S, Mandl K. Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov. Ann Intern Med. 2010;153:158-66.
  8. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smith R, et al. The Impact of Outcome Reporting Bias in Randomised Controlled Trials on a Cohort of Systematic Reviews. BMJ. 2010;340:c365.
  9. Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ. 2010;341:c4737.
  10. Buñuel Álvarez JC, González de Dios J. Los ensayos clínicos financiados por la industria tienen mayor probabilidad de encontrar resultados favorables al fármaco objeto de estudio. Evid Pediatr. 2010;6:77.

Related Articles

AVC | Industry funded trials are more likely to find favorable outcomes

Buñuel Álvarez JC, González de Dios J. Los ensayos clínicos financiados por la industria tienen mayor probabilidad de encontrar resultados favorables al fármaco objeto de estudio. Evid Pediatr. 2010;6:77.
18/11/2010

Linked Comment